330 related articles for article (PubMed ID: 12749753)
1. Stealth nucleosides: mode of action and potential use in the treatment of viral diseases.
Daifuku R
BioDrugs; 2003; 17(3):169-77. PubMed ID: 12749753
[TBL] [Abstract][Full Text] [Related]
2. The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides.
Magee WC; Evans DH
Antiviral Res; 2012 Nov; 96(2):169-80. PubMed ID: 22960154
[TBL] [Abstract][Full Text] [Related]
3. Viral error catastrophe by mutagenic nucleosides.
Anderson JP; Daifuku R; Loeb LA
Annu Rev Microbiol; 2004; 58():183-205. PubMed ID: 15487935
[TBL] [Abstract][Full Text] [Related]
4. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
Delaney WE; Locarnini S; Shaw T
Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
[TBL] [Abstract][Full Text] [Related]
5. Acyclic nucleoside phosphonates: a new dimension to the chemotherapy of DNA virus and retrovirus infections.
De Clercq E
J Med Microbiol; 1998 Jan; 47(1):1-3. PubMed ID: 9449944
[No Abstract] [Full Text] [Related]
6. Antiviral drug discovery and development: where chemistry meets with biomedicine.
De Clercq E
Antiviral Res; 2005 Aug; 67(2):56-75. PubMed ID: 16046240
[TBL] [Abstract][Full Text] [Related]
7. Hamao Umezawa Memorial Award Lecture: "An Odyssey in the Viral Chemotherapy Field".
De Clercq E
Int J Antimicrob Agents; 2001 Oct; 18(4):309-28. PubMed ID: 11691563
[TBL] [Abstract][Full Text] [Related]
8. Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure.
Miller V; Larder BA
Antivir Ther; 2001; 6 Suppl 3():25-44. PubMed ID: 11678471
[TBL] [Abstract][Full Text] [Related]
9. The future of antivirals: broad-spectrum inhibitors.
Debing Y; Neyts J; Delang L
Curr Opin Infect Dis; 2015 Dec; 28(6):596-602. PubMed ID: 26524332
[TBL] [Abstract][Full Text] [Related]
10. Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis.
Qiu L; Patterson SE; Bonnac LF; Geraghty RJ
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006421. PubMed ID: 29672522
[TBL] [Abstract][Full Text] [Related]
11. Lethal mutagenesis of HIV with mutagenic nucleoside analogs.
Loeb LA; Essigmann JM; Kazazi F; Zhang J; Rose KD; Mullins JI
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1492-7. PubMed ID: 9990051
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of Nucleosides and Non-nucleosides Based 4,6-disubstituted-2-oxo-dihydropyridine-3-carbonitriles as Antiviral Agents.
Ibrahim TS; El-Sayed HA; Khayat MT; Al-Mahmoudy AMM; Moustafa AH; El-Deen AKS; Rostom SAF; Panda SS
Med Chem; 2018; 14(8):791-808. PubMed ID: 29788895
[TBL] [Abstract][Full Text] [Related]
13. Emetine inhibits replication of RNA and DNA viruses without generating drug-resistant virus variants.
Khandelwal N; Chander Y; Rawat KD; Riyesh T; Nishanth C; Sharma S; Jindal N; Tripathi BN; Barua S; Kumar N
Antiviral Res; 2017 Aug; 144():196-204. PubMed ID: 28624461
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial strategies: inhibition of viral polymerases by 3'-hydroxyl nucleosides.
Deval J
Drugs; 2009; 69(2):151-66. PubMed ID: 19228073
[TBL] [Abstract][Full Text] [Related]
15. Highly efficient random mutagenesis in transcription-reverse-transcription cycles by a hydrogen bond ambivalent nucleoside 5'-triphosphate analogue: potential candidates for a selective anti-retroviral therapy.
Moriyama K; Otsuka C; Loakes D; Negishi K
Nucleosides Nucleotides Nucleic Acids; 2001 Aug; 20(8):1473-83. PubMed ID: 11554540
[TBL] [Abstract][Full Text] [Related]
16. [Isoprinosine: evaluation of its virus inhibiting action in vivo and in vitro].
Eggers HJ; Neufahrt A; Rolly H
Dtsch Med Wochenschr; 1972 Aug; 97(31):1156-9. PubMed ID: 4339680
[No Abstract] [Full Text] [Related]
17. Effective lethal mutagenesis of influenza virus by three nucleoside analogs.
Pauly MD; Lauring AS
J Virol; 2015 Apr; 89(7):3584-97. PubMed ID: 25589650
[TBL] [Abstract][Full Text] [Related]
18. KP-1212/1461, a nucleoside designed for the treatment of HIV by viral mutagenesis.
Harris KS; Brabant W; Styrchak S; Gall A; Daifuku R
Antiviral Res; 2005 Jul; 67(1):1-9. PubMed ID: 15890415
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity spectrum of phenoxazine nucleoside derivatives.
Kozlovskaya LI; Andrei G; Orlov AA; Khvatov EV; Koruchekov AA; Belyaev ES; Nikolaev EN; Korshun VA; Snoeck R; Osolodkin DI; Matyugina ES; Aralov AV
Antiviral Res; 2019 Mar; 163():117-124. PubMed ID: 30684562
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B and C virus resistance to antiviral therapies--EASL-AASLD-APASL-ALEH-IASL conference.
Buti M
IDrugs; 2008 Apr; 11(4):239-41. PubMed ID: 18379952
[No Abstract] [Full Text] [Related]
[Next] [New Search]
